Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $324.11, but opened at $309.32. Astera Labs shares last traded at $314.3980, with a volume of 855,276 shares changing hands.
Analysts Set New Price Targets
A number of brokerages have weighed in on ALAB. Barclays upped their price target on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Friday. UBS Group reissued a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Royal Bank Of Canada raised their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Finally, Roth Capital restated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $348.33.
Check Out Our Latest Research Report on Astera Labs
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 2.70 earnings per share for the current year.
Insider Transactions at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Astera Labs
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GK Wealth Management LLC bought a new position in Astera Labs in the third quarter worth $29,000. Cadent Capital Advisors LLC bought a new stake in Astera Labs in the 3rd quarter valued at $1,845,000. Farther Finance Advisors LLC raised its stake in shares of Astera Labs by 102.8% in the 3rd quarter. Farther Finance Advisors LLC now owns 6,043 shares of the company’s stock valued at $2,151,000 after buying an additional 3,063 shares in the last quarter. CoreCap Advisors LLC raised its stake in shares of Astera Labs by 21.0% in the 3rd quarter. CoreCap Advisors LLC now owns 749 shares of the company’s stock valued at $267,000 after buying an additional 130 shares in the last quarter. Finally, Cooper Financial Group bought a new position in shares of Astera Labs during the 3rd quarter worth about $203,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.
Featured Articles
- Five stocks we like better than Astera Labs
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
- Flex’s AI Infrastructure Spin-Off Could Unlock Hidden Value
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
